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General introduction 
 
Tablets are a very commonly and widely used dosage form for the oral administration of 
drugs.1 Tablets have advantages over other dosage forms of drug delivery, such as 
physicochemical stability, accurate dosages and the ease of drug-release control. Moreover, 
tablets are convenient for patients because they are portable and easy to administer. The 
optimum manufacturing condition is varied by a kind and an amount of active ingredient 
because characteristics of active ingredient have an influence on pharmaceutical 
characteristics.2 In addition, the relationships among the design variables and pharmaceutical 
characteristics are intricate since there are numerous factors that must be taken into account. 
Therefore, the expertise and experience of formulators are essential for the design of an 
acceptable product formulation and of a manufacturing process. However, the empirical 
approach requires a long development time and significant resources. 
In recent years, the application of statistical methods to pharmaceutical development has 
been implemented, to allow International Conference on Harmonisation (ICH) Q trio 
guidance (Q8, Q9, and Q10).3–5 The ICH Q8(R2) guideline announced that pharmaceutical 
design and development should be based on science, rather than being based on empirical 
knowledge only. The concept of “quality by design” (QbD) is described in the ICH Q8 
recommendations, which propose that the design and development of pharmaceutical 
formulations and manufacturing processes should ensure the prescribed quality by 
understanding how these factors affect the quality of pharmaceutical products. This requires 
the use of a combination of chemometric treatments, including the design of experiments 
(DOE), the response surface method (RSM), and multivariate analyses. 
DOE is a structured and organized technique to determine the factors that may influence a 
product or process. DOE overcomes the problems associated with one-component-at-a-time 
experiments that cannot clarify interactive effects between factors. DOE also helps us 
understand how typical fluctuations around mean input values can influence the final product. 
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The response surface method (RSM) is used for DOE analysis and resolving optimization 
problems.6–12 However, predictions based on the quadratic polynomial method are sometimes 
limited, and the results obtained occasionally exhibit poor estimation. To overcome this 
problem, a nonlinear response surface method incorporating multivariate spline interpolation 
(RSM-S) was developed. The basic concept of multivariate spline interpolation involves a 
boundary element method.13 Green’s functions are used for minimum curvature interpolation 
of multidimensional data points. Prediction accuracy of RSM-S is higher than conventional 
techniques such as the quadratic polynomial method and multiple regression analysis in a lot 
of cases. In addition, this method does not require any complicated methodology such as an 
artificial neural network, and it has been applied to practical cases to optimize pharmaceutical 
formulations. 
To date, various results have suggested that RSM-S is a potential tool for pharmaceutical 
tablet manufacturing process.14–18 However, several difficulties are yet to be overcome 
regarding a non-linear technique such as RSM-S. For instance, there are no proper method of 
analyzing the relationships of the latent structure among the design variables and response 
variables, and evaluating the reliability of border on design space (DS) estimated by RSM-S. 
Moreover, the mechanistic understanding of pharmaceutical unit operations is limited. The 
purpose of this study was to overcome these problems and establish valuable tools for the 
pharmaceutical design under the QbD concept. 
In Chapter 1, I attempted to clarify the latent structure underlying the causal factors and 
pharmaceutical responses of a tablet containing solid dispersion (SD) of indomethacin (IMC) 
using a Bayesian network (BN). In Chapter 2, a reliability of border on the DS estimated by 
RSM-S was evaluated using a resampling method with replacement. In Chapter 3, a 
multivariate statistical technique was applied to the design of an orally disintegrating tablet 
and to clarify the causal correlation among variables of the manufacturing process and 
pharmaceutical responses. In Chapter 4, the mechanical behavior of pharmaceutical powders 
during compaction was analyzed using the finite element method (FEM). I evaluated 
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differences in stress distribution between tablets composed of various formulations. Moreover, 
the predictive abilities of tablet characteristics of tensile strength and disintegration time on 
residual stress distribution were investigated.  
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Chapter 1 
 
Modeling of latent structure of indomethacin solid dispersion tablet using 
Bayesian networks 
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1. Introduction 
The solid dispersion (SD) system is one of the methods used to enhance the dissolution 
rates of drugs with limited water solubility in inert carriers. Many studies of SD carriers have 
been reported19. Polyvinylpyrrolidone (PVP) is recognized as a superior polymer for use as an 
SD carrier.20–22 However, there are several disadvantages of the SD method, including 
manufacturing difficulties, i.e. the SD powders are generally soft and tacky with poor 
flowability and compressibility.23 Therefore, the SD is rather difficult to handle when a tablet 
is chosen as the final product formulation. 
A Bayesian network (BN) is potentially useful in formulation development. BN is a 
directed acyclic graphical approach that expresses the probabilistic causal relationships 
among attributes, in which probabilistic relationships are expressed by nodes and the links 
connecting the nodes.24 BN offers many advantages over a sample of all possible observations. 
From the influence diagram, the dependence, independence, and/ or interdependence of 
variables can be determined visually as parents and offspring. In addition, not all probabilities 
or relationships need to be known or calculated to make a decision; adventitious relationships 
can essentially be ignored. I can easily determine the model structure and dependency 
between variables as parameters of the conditional probability distribution by using BN. 
Recently, BN has been used widely in various fields, including applied statistics, medicine, 
and bioinformatics.25–28 
The purpose of this chapter was to clarify the latent structure underlying the causal factors 
and pharmaceutical responses involved in preparing indomethacin (IMC) SD tablets with high 
hardness and high storage stability. 
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2. Materials and methods 
2.1. Materials 
Indomethacin (IMC), a model poorly water-soluble drug, and magnesium stearate (Mg-St) 
were purchased from Wako Pure Chemical Industries, Ltd (Osaka, Japan). 
Polyvinylpyrrolidone (PVP) K30 was purchased from Sigma-Aldrich Co., Ltd (St Louis, MO, 
USA). Microcrystalline cellulose (MCC; Ceolus PH-101, Asahi Kasei Chemicals Co., Ltd, 
Tokyo, Japan), lactose (LAC; 200-mesh grade, DMV International, Veghel, the Netherlands), 
low-substituted hydroxypropylcellulose (L-HPC; LH-21, Shinetsu Chemical Co., Japan), and 
corn starch (CS; Nihon Shokuhin Kako Co., Ltd, Tokyo, Japan) were gifts from Daiichi 
Sankyo Co., Ltd (Tokyo, Japan). 
 
2.2. Preparation of SDs and physical mixtures 
An IMC/PVP SD was prepared using the solvent evaporation technique. Equal parts of 
IMC and PVP were dissolved in 95% (v/v) ethanol at 60 °C to produce a clear solution. The 
solvent was then removed at reduced pressure (14 mmHg) at 60 °C, using a rotary evaporator. 
The final residue was maintained at reduced pressure for 24 h to completely eliminate the 
solvent. It was then milled and the particles passed through a 250 µm sieve. These were then 
stored in a desiccator over silica gel to prevent their absorption of humidity. This sample was 
analyzed by differential scanning calorimetry (DSC; Thermo plus DSC 8230, Rigaku, Tokyo) 
and a powder X-ray diffractometer (XRD; RINT-1400 X-ray diffractometer, Rigaku, Tokyo), 
and the amorphous state of the IMC was confirmed. A physical mixture (PM) was obtained 
by blending IMC and PVP in a polyethylene bag. 
 
2.3. Experiment design 
An L16 (25) fractional factorial experimental design was used to evaluate the relative 
contributions of the effects of the causal factors. The IMC tablets prepared as SD or PM (X1), 
the quantities of Mg-St (X2), MCC (X3), and L-HPC (X4), and the compression force (X5) were 
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selected as the causal factors. The 16 kinds of tablet formulations prepared are summarized in 
Table 1. The total mass of each tablet was adjusted to 200 mg using LAC and CS in a ratio of 
7:3 (w/w). 
 
Table 1. Test formulations composed of five causal factors based on an L16 (25) fractional 
factorial experimental design and their response variables 
  Causal factors 
 
Response variables 
Rp. 
X1 
X2 X3 X4 X5 
 
D10 D60 TS f2 
 
(%) (%) (%) (kN) 
 
(%) (%) (MPa) (%) 
1 SD 1 5 5 8 
 
24.7±2.0 49.7±2.1 1.002±0.065 41.5±3.3 
2 SD 1 5 15 12 
 
17.6±1.1 56.7±1.9 1.337±0.069 41.6±1.0 
3 SD 1 15 5 12 
 
29.9±3.1 63.6±4.8 1.026±0.068 58.5±9.6 
4 SD 1 15 15 8 
 
36.0±4.5 59.6±1.9 1.093±0.066 51.9±1.8 
5 SD 3 5 5 12 
 
25.3±0.8 67.8±1.5 0.658±0.119 53.5±8.9 
6 SD 3 5 15 8 
 
41.6±3.5 68.0±2.4 0.447±0.031 75.3±9.6 
7 SD 3 15 5 8 
 
41.5±2.8 69.8±2.4 0.522±0.041 72.7±10.0 
8 SD 3 15 15 12 
 
19.6±1.6 66.8±4.5 0.601±0.011 47.8±3.3 
9 PM 1 5 5 12 
 
19.3±1.9 30.5±0.5 0.882±0.065 82.2±8.2 
10 PM 1 5 15 8 
 
21.4±0.4 31.4±0.5 0.844±0.043 69.6±0.9 
11 PM 1 15 5 8 
 
17.1±1.5 29.1±0.1 1.100±0.095 78.0±6.6 
12 PM 1 15 15 12 
 
18.9±1.7 30.5±0.7 1.480±0.037 76.8±2.8 
13 PM 3 5 5 8 
 
21.8±2.0 37.9±0.4 0.540±0.118 79.3±4.3 
14 PM 3 5 15 12 
 
20.4±5.8 40.9±4.3 0.770±0.063 74.7±5.0 
15 PM 3 15 5 12 
 
17.7±2.2 38.7±0.9 1.055±0.103 74.9±6.2 
16 PM 3 15 15 8 
 
21.2±3.7 39.1±0.3 1.017±0.063 70.8±7.3 
X1 is the IMC tablets prepared as solid dispersions (SD) or physical mixture (PM). 
X2 is the quantities of magnesium stearate (Mg-St). X3 is the quantities of 
microcrystalline cellulose (MCC). X4 is the quantities of low-substituted 
hydroxypropyl (L-HPC). X5 is the compression force. D10 and D60 are dissolution 
rates at 10 and 60 min, respectively. TS is tensile strength. f2 is similarity factor. 
 
2.4. Preparation of IMC tablets 
All ingredients were dried at 75 °C for 12 h. The ingredients were accurately weighed 
according to the experimental formulations and all the ingredients were blended in a 
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polyethylene bag for 2 min. The final blend was directly compressed into round-faced tablets 
(200 mg, 8 mm diameter) with a tableting machine (Handtab-100, Ichihachi-Seiki Co., Ltd, 
Kyoto, Japan). 
 
2.5. Dissolution test 
The dissolution test was performed with a JP XV dissolution test apparatus (paddle 
method) using 900 mL purified water  at 37 °C with stirring at 50 rpm. The samples were 
withdrawn and filtered after 5, 10, 15, 20, 30, 40, 50, and 60 min. The IMC concentration in 
the medium was measured spectrophotometrically at 320 nm with a Jasco Ubest-30 
spectrophotometer (Japan Spectroscopic Co. Ltd, Tokyo, Japan). The dissolution rates of the 
IMC tablets at 10 min (D10) and at 60 min (D60), measured before and after the accelerated 
test, were selected as the pharmaceutical responses. The dissolution rates of three tablets of 
each formulation were measured. 
 
2.6. Hardness test 
The hardness of the tablet was determined with the Tablet Hardness Tester (Ogawa Seiki 
Co., Tokyo, Japan). Tensile strength (TS) was calculated as: TS = !"!!"         (1) 
where F is the maximal diametrical crushing force, and d and t are the diameter and 
thickness of the tablet, respectively. The TSs of three tablets of each formulation were 
measured. 
 
2.7. Accelerated test 
To evaluate the effects of stress conditions on the dissolution profiles and TS, the 
accelerated test was performed by storing the tablets at 40 °C and 75% relative humidity for 
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two weeks in a stability chamber (CSH-110; ESPEC Co., Osaka, Japan). The samples were 
then stored in a desiccator over silica gel at room temperature. 
 
2.8. Evaluating the storage stability of IMC tablets 
The similarity factor (f2) was used to evaluate the similarity of the dissolution profiles 
before and after the accelerated test. f2 is a measure of the similarity in the percentage 
dissolution between two curves.29 In this study, f2 was used as the criterion of storage stability 
of the dissolution profiles from 5 min to 60 min. 
 
2.9. Analysis of variance 
To evaluate the significance of the effect of causal factors and their interactions, the data 
obtained from the experimental design were analyzed by analysis of variance (ANOVA). The 
revised sum of squares (S′) obtained by subtracting the mean square of the error term from the 
mean square of each factor was used to estimate the contribution ratio. Contribution ratios of 
less than 5% were pooled as the error term. 
 
2.10. BN model construction 
The BayoNet System software, version 4.0.2 (Mathematical Systems Inc., Tokyo, Japan) 
was used to determine the BN structure. In this study, a greedy search strategy is applied as 
the K2 algorithm in the learning process of a BN. The K2 algorithm, which is a study 
algorithm for this type of graph structure, is the most famous score-based algorithm in 
Bayesian networks, and it automatically leads to the network structure from the statistical 
data.30 The procedure of this search algorithm is as follows: (1) the candidates are limited that 
can become new nodes for each node; (2) a child node is selected, and addition of the 
candidate nodes are made one by one to make a graph of the network; (3) the estimated 
network is evaluated using statistical parameters; (4) only when the network is highly 
evaluated is it used as a new node; (5) when there are no more new additional node candidates 
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or the highest evaluation has been obtained, another child node is selected; and (6) the 
procedure of (1) to (5) is repeated for all child nodes. As measures of appropriateness, 
Akaike’s information criterion (AIC), minimum description length (MDL), and maximum log 
likelihood (ML) were used. To construct the BN, candidates for the parent node (explanatory 
variable) were required. In this study, the factors were assigned as the candidates, and the 
responses of the tablets (D10, D60, and TS) were assigned as the child nodes (dependent 
variables). The responses of the tablets were discretized into three categories (low, medium, 
and high) using the K-means method on the BayoNet system. 
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3. Results 
3.1. Responses before and after the accelerated test 
Figure 1 shows the dissolution profiles for IMC from formulations Rp.2, Rp.7, Rp.11, and 
Rp.13, shown as typical examples. Before the accelerated test, the D60 values for the SD 
tablets were higher than those for the PM tablets, as summarized in Table 1. After the 
accelerated test, the initial dissolution rate was increased in the SD tablets, although that of 
the PM tablets had hardly changed. When analyzed by DSC and XRD, no recrystallization of 
IMC was seen in the SD tablets after the accelerated test (data not shown). Table 1 also shows 
the TS values for the test formulations before the accelerated test. The TS values for the PM 
tablets improved after the accelerated test, although those of the SD tablets were hardly 
changed (data not shown). 
 
Fig. 1. Typical examples of the dissolution profiles of IMC tablets. (▲) Rp.2, (●) 
Rp.7, (■) Rp.11, and (◆) Rp.13 (a) before and (b) after the accelerated test. 
 
3.2. Evaluation of causal relationships using ANOVA 
To clarify the causal relationships between the formulation factors and the pharmaceutical 
responses, ANOVA was applied before the BN analysis. The causal factors X1 and X5 and the 
two interactions X1 × X5 and X4 × X5 significantly affected D10, and the contributions of X1 and 
X5, in particular, were extremely high compared with those of the other factors. The 
contribution ratios for D60 indicated that more than 80% of the variance was attributable to X1. 
Furthermore, X2 strongly affected the TS values, and X1 significantly affected the f2 factor. 
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3.3. Visualization of the latent structure using BN 
To visualize the latent structure between the causal factors and the responses, a BN method 
was applied to the data points. The optimal BN models were predicted using AIC, MDL, and 
ML as the judging standards (Fig. 2). The numbers of links in the BN models based on AIC, 
MDL, and ML were 9, 5, and 16, respectively. The BN model with MDL was the simplest 
and the model with ML was the most complicated. The intermediate model was obtained with 
AIC. These BN models were compared with the results obtained with ANOVA. Because the 
model based on AIC was closest to the results of ANOVA, it is likely that the AIC model 
appropriately demonstrates the latent structure of the tablet formulation containing IMC SD. 
D10 was affected by X1, X4, and X5, D60 was affected by X1 and X4, and TS was affected by X1, 
X2, and X3. The factor f2 correlated predominantly with X1. 
 
Fig. 2. Network models between causal factors and responses estimated by (a) ANOVA and 
(b)–(d) BN models based on three judging standards (b) Akaike’s information criterion 
(BN-AIC), (c) minimum description length (BN-MDL), and (d) maximum log likelihood 
(BN-ML). The nodes correspond to the causal factors and pharmaceutical responses, respectively, 
and the links represent the dependencies between them. 
 
 13 
 
3.4. Prediction of the responses using BN 
The responses were predicted using conditional probability distributions (CPDs). As 
shown in Fig. 3a, the CPDs indicated whether SD or PM was crucial to the high or low values 
for D10. The SD tablets produced with 15% L-HPC and 8 kN compression force resulted in 
the highest D10 value. In contrast, the lowest D10 value occurred when the tablets were made 
with PM and 12 kN compression force. When the tablets contained SD and 3% Mg-St, high 
D60 values were observed. In contrast, low D60 was predicted when the tablets were made of 
PM and 1% Mg-St (Fig. 3b). TS was lower when the quantity of Mg-St was high (3%). The 
tablets with PM, 1% Mg-St, and 15% MCC resulted in high values for TS. However, the 
tablets with SD and 3% Mg-St had low TS values (Fig. 3c). The SD tablets showed a 
tendency for low f2, whereas the PM tablets had high f2 (Fig. 3d). The dissolution profiles 
before and after the accelerated test were less similar when SD was used in the tablets. 
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Fig. 3. Conditional probability distributions (CPDs) of the pharmaceutical responses 
(a) D10, (b) D60, (c) TS, and (d) f2 inferred by BN. Causal factors associated with each 
response are set as prior probabilities. CPDs of the responses are estimated for overall 
combinations of the causal factors. 
 
3.5. Prediction of causal factors using a BN model 
With BN modeling, the posterior probability of the causal factors is also predicted using 
CPDs. To clarify the effects on D10 and D60, the posterior probabilities of the causal factors 
were predicted from D10 and D60. When the tablets had a low D60, the BN model inferred a 
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formulation with IMC PM. When the tablets had a low D10 and a high D60, the BN model 
inferred a formulation with IMC SD, high quantities of Mg-St and L-HPC, and a high 
compression force. Conversely, when the tablets had a high D10 and a high D60, the BN model 
inferred a formulation with IMC SD, large quantities of Mg-St and L-HPC, and a low 
compression force. Furthermore, the tablets that had low D10 and high D60 required a much 
higher compression force than did the tablets with high D10 and high D60 (Fig. 4). 
 
Fig. 4. Conditional probability distributions (CPDs) of causal factors inferred by 
BN. Dissolution properties are set as the prior probabilities. The CPDs of the causal 
factors are estimated for four cases: low D10 and low D60; high D10 and low D60; 
high D10 and low D60; and high D10 and high D60. 
 
To predict an IMC tablet with excellent properties, i.e., high dissolution rate, high hardness, 
and stable storage properties, the posterior probabilities of the causal factors were predicted. 
IMC SD, low quantities of Mg-St and MCC, a high quantity of L-HPC, and 8 kN 
compression force were estimated to be the best combination of causal factors (Fig. 5). 
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Fig. 5. Conditional probability distributions (CPDs) of causal factors 
inferred by BN. CPDs of the causal factors were estimated for the 
best combination of response variables, such as high values for D10, 
D60, TS, and f2. 
 
A leave-one-out cross-validation study was performed to evaluate the prediction accuracy 
of the BN model. The classification accuracies for D10, D60, TS, and f2 were shown to be 
83.3%, 83.3%, 77.1%, and 62.5%, respectively, suggesting that the BN model classified the 
responses into each category well. 
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4. Discussion 
In the development of pharmaceutical formulations, the relationships between causal 
factors and pharmaceutical responses are often complex. It is also difficult to determine these 
relationships quantitatively. A BN is a graphical probabilistic model consisting of nodes as 
the variables and links as the dependencies among the variables. In this study, a BN model 
was used to clarify the relationships underlying the causal factors and responses in IMC tablet 
formulations. 
The D60 values of the IMC SD tablets were higher than those of the IMC PM tablets, 
whereas the D10 values of the IMC SD tablets were not always higher than those of the IMC 
PM tablets before the accelerated test. This result suggests that the SD state of IMC strongly 
affected D60, although other factors were also important in improving the initial dissolution 
rate. Overall, the dissolution rate was better in the tablets containing IMC SD after the 
accelerated test. 
An L16 (25) fractional factorial experimental design was used to estimate the relative 
intensities of the influences of five causal factors on the tablet qualities. First, the data were 
analyzed by ANOVA. The initial dissolution rate, D10, was strongly affected by X1 (SD or 
PM). This suggests that the solubility of IMC and the disintegration of the tablets were higher 
in the IMC SD tablets than in the IMC PM tablets. Because the SD particle itself has very 
rapid dissolution properties, it is likely that the IMC SD tablet disintegrates easily. Therefore, 
the initial dissolution of the IMC SD tablets produced high values for D10. The factors X4 
(L-HPC) and X5 (compression force) were associated with D10 because L-HPC works as an 
effective disintegrant and disintegration is also affected by the compression force. Similar 
results have been reported in previous papers.31–32 D60 was strongly affected by X1 (SD or 
PM) and X2 (Mg-St). In contrast, the TS value was affected by the factors X1, X2, X3, and X5. 
Among these, the effect of X2 (Mg-St) was strongest. Mg-St reduces the interparticle binding 
strength, so the hardness of the tablet decreases as the quantity of Mg-St increases. More 
often than not, a reduction in the hardness of the tablet increases the dissolution rate. 
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To analyze the latent structure of the causal factors and responses in IMC tablets, BN 
models were constructed based on AIC, MDL, and ML as the judging criteria (Fig. 2). All 
models showed that X1 (SD or PM) affected D10, D60, and f2; X2 (Mg-St) affected TS; and X5 
(compression force) affected D10. Furthermore, the BN modeling results were close to the 
results observed with ANOVA. 
BNs efficiently implement the probabilistic inference algorithm, which estimates the 
probability distribution of arbitrary random variables in a model.33–34 The CPDs of the 
responses of the IMC tablet were predicted using the BN model based on the AIC. When the 
tablets were composed of IMC SD, high values for both D10 and D60 were predicted, and vice 
versa. The effects of MCC and Mg-St on the TS values were observed with BN modeling. 
The posterior probabilities of the responses for various combinations of causal factors were 
appropriately estimated (Fig. 3). The BN model was able to estimate not only the effects of 
the causal factors on each response, but also the trends in the responses produced by the 
formulations as CPDs. The results indicate that BN models can reveal the relationships 
between the causal factors and responses in IMC tablet formulations. Regardless of changes 
in the D10 value, the tablets with a low D60 contained IMC PM. This suggests that D60 was 
strongly affected by whether the IMC was in the SD or PM form. The BN model implied that 
IMC SD, large quantities of Mg-St and L-HPC, and a compression force of 8 kN, in that order, 
were likely to increase D10 and D60. Because L-HPC acts as an effective disintegrant, the 
initial dissolution is significantly influenced by the amount of L-HPC. Moreover, the 
compression force used in the manufacture of the tablets differed greatly between tablets with 
low and high D10 values, suggesting that the initial dissolution of IMC was also affected by 
the compression force (Fig. 4).  
The CPDs of the causal factors were investigated. To prepare tablets with excellent 
properties, low quantities of Mg-St and MCC, a large L-HPC component, and a low 
compression force are suggested (Fig. 5). The BN technique can be used to predict 
formulations with excellent pharmaceutical properties. 
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5. Conclusion 
The latent structure underlying the causal factors and responses of IMC tablets was 
modeled using the BN technique. The AIC-based BN model correlated strongly with the 
contribution ratio estimated with ANOVA. The complex relationships between causal factors 
and pharmaceutical responses were successfully determined using BN modeling. Moreover, 
both the causal factors and responses were predicted by the BN model using CPDs. This 
suggests that the combination of causal factors was predicted appropriately as posterior 
probabilities. We conclude that the BN technique is useful for understanding the latent 
structure underlying tablet formulations.  
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Chapter 2 
 
Reliability evaluation of the nonlinear design space in pharmaceutical 
product development  
 21 
 
1. Introduction 
In the previous chapter, I have applied a BN model to clarify the latent structure 
underlying the causal factors and pharmaceutical responses of a tablet. However, it is difficult 
to quantitatively predict pharmaceutical responses using BN because factors must be 
discretized before model construction. 
In ICH Q8(R2), it is intended to provide approaches to the rational development of the 
design space, which is defined as the multidimensional combination and interaction of input 
variables and process parameters that have been demonstrated to provide quality assurance. 
Therefore, the design space must be established to identify the multidimensional 
combinations and interactions of the many causal factors that determine the quality of the 
target so that working within the design space is not a postapproval change.35  
The RSM may be a powerful tool for proposing a method to set up the design space (DS). 
The DS is represented by the RSM resolved at the limit of a satisfactory response and is 
determined from the region of successful operating ranges for multiple critical quality 
attributes (CQAs). The overlaps of some response surface models for multiple quality 
attributes enable the generation of a common design space with successful operating ranges. 
Using RSM-S, we can understand nonlinear relationships between causal factors and 
response variables, and can estimate the high-integrity design space. It is not always easy to 
ensure quality with a high probability when a tablet formulation or process parameter is 
located at the border of the design space, and it becomes necessary to clarify the credibility 
inside the border of the design space. However, the reliability of the nonlinear response 
surface estimated by RSM-S cannot be evaluated directly using conventional statistical 
quantities. Thus, we applied a resampling method with replacement to evaluate the reliability 
of the border of DS predicted by RSM-S. The resampling method, similar to a bootstrap 
resampling method, is a simulation technique based on the empirical distribution of the 
experimental samples and can be used to evaluate the reliability of the optimal solution 
estimated by the RSM-S.36–38 Skewness and kurtosis were used as the statistical indices to 
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evaluate the normality of the distribution of the design space border determined with 
resampling. 
The main goal of this chapter was to evaluate the reliability of the border of the nonlinear 
design space estimated with RSM-S using a resampling method and to set up a conservative 
design space considering the reliability of the border. As the model experiment, formulation 
optimization of indomethacin tablets was conducted. 
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2. Materials and methods  
2.1. Materials 
Indomethacin, as a model drug, and magnesium stearate (Mg-St) were purchased from 
Hachidai Pharmaceutical Co. Ltd. (Osaka, Japan) and Wako Pure Chemical Industries, Ltd 
(Osaka, Japan), respectively. Polyvinylpyrrolidone (PVP) K30 was a gift from Nippon 
Shokubai Co., Ltd. (Osaka, Japan). Microcrystalline cellulose (MCC; Ceolus PH-101, Asahi 
Kasei Chemicals Co., Ltd., Tokyo, Japan), lactose (200-mesh grade, DMV International, 
Veghel, the Netherlands), and cornstarch (CS; Nihon Shokuhin Kako Co., Ltd., Tokyo, Japan) 
were gifts from Daiichi Sankyo Co., Ltd. (Tokyo, Japan). 
 
2.2. Preparation of IMC 
All ingredients were dried at 75 °C for 12 h. The ingredients were weighed accurately 
according to the experimental formulations, and all ingredients were blended in a 
polyethylene bag for 2 min. The final blend was compressed directly into round-faced tablets 
(200 mg, 8 mm diameter, 12 mm radius of curvature) using a tableting machine (Handtab-100, 
Ichihachi-Seiki Co., Ltd., Kyoto, Japan). The compression force was about 10 kN. All 
formulations comprised 25 mg of Indomethacin; 161 mg of a mixture of lactose, CS, and 
MCC; 12 mg of PVP; and 2 mg of Mg-St. 
 
2.3. Experimental design 
Various amounts of lactose (X1), CS (X2), and MCC (X3) were selected as the formulation 
factors. Based on the preliminary experiments, the lower and upper limits of the levels of each 
factor were set as follows: 
0 ≤ X1 ≤ 112.70 (mg)  (2) 
48.30 ≤ X2 ≤ 161.00 (mg) (3) 
0 ≤ X3 ≤ 88.55 (mg) (4) 
X1 + X2 + X3 = 161.00 (mg). (5) 
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Therefore, the feasible experimental region in the simplex-lattice design was a trapezoidal 
shape. The formulation factors were assigned according to an extreme vertices design, as 
shown in Figure 6, and nine kinds of formulations, including duplicates of the centroid, were 
prepared.39 
 
Fig. 6. Geometric representation of the experimental designs: extreme 
vertices design for three components. Nine formulations were assigned to 
the extreme vertices design in this study. 
 
2.4. Hardness test and dissolution test 
The hardness of the tablet was determined using a Tablet Hardness Tester (Ogawa Seiki 
Co., Tokyo, Japan). The hardness of three tablets of each formulation was measured. 
The dissolution profiles of the tablets were investigated using a dissolution apparatus (JP 
XV Toyama Sangyo). The dissolution test apparatus was used for the dissolution test with the 
paddles method (JP XV) at 50 rpm using 900 mL of Japanese Pharmacopoeia XV second 
fluid (pH 6.8, 0.05 M H2 KPO4 and 0.0236 M NaOH) at 37 °C with stirring at 50 rpm. The 
samples were withdrawn and filtered after 3, 6, 9, 12, 15, 20, 30, and 40 min. The 
indomethacin concentration was measured spectrophotometrically at 320 nm with a Jasco 
Ubest-30 spectrophotometer (Japan Spectroscopic Co. Ltd., Tokyo, Japan). The dissolution 
rates of the indomethacin tablets at 30 min (D30), measured before and after the accelerated 
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test, were selected as the pharmaceutical responses. The dissolution rates of three tablets of 
each formulation were measured. 
 
2.5. Accelerated test 
To evaluate the effects of stress conditions on hardness and the dissolution profiles, the 
accelerated test was performed by storing the tablets at 40 °C and 75% relative humidity for 4 
weeks in a stability chamber (CSH-110; ESPEC Co., Osaka, Japan). The samples were then 
stored in a desiccator over silica gel at room temperature. 
 
2.6. Setup of design space and reliability assessment of the design space border using the 
RSM-S and resampling technique 
We used the resampling technique with replacement to evaluate the reliability of the design 
space border (Fig. 7). First, the design space was estimated based on the RSM-S using a data 
set obtained with an extreme vertices design. The resampling method was then applied to 
evaluate the reliability of the design space. The number of resamplings with replacement was 
fixed at 500. From the distribution of the resampling border of the design space, 95% 
confidence intervals (CIs) for the border of the original design space were calculated. When a 
lack in one or more formulation was found in the process of resampling, the relevant 
resampling sets were deleted from the analysis as “data set with a lack”. That is, the 
resampling set was arranged to include one or more data points for every formulation. This 
process is shown in Figure 7. 
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Fig. 7. Resampling process for evaluating the reliability of the border of the 
design space estimated by RSM-S. 
 
Skewness ($3) and kurtosis ($4), indices of the normality of the histograms of the 
resampling borders of the design space, were calculated as: 
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where n is the number of the resampling borders of the design space (xi),  is the mean 
of xi, and s is the sample standard deviation. When the indices $3 and $4 are close to 0, the 
histograms of the resampling border of the design space are close to a normal distribution. 
 
2.7. Computer programs 
RSM-S was performed using dataNESIA® version 3.2 (Yamatake Corp., Fujisawa, Japan). 
Resampling method with replacement was applied with dataNESIA® version 3.2 (Yamatake 
Corp., Fujisawa, Japan) and Microsoft Excel® for Windows 2007, and the macroprograms 
x
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were written by the authors with Visual Basic version 6.5 (Microsoft Corp., Tokyo, Japan). 
The multiple linear regression analysis was performed using Microsoft Excel® for Windows 
2007. 
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3. Results 
3.1. Prediction of the response variables using RSM-S 
The hardness and D30 before and after the accelerated test were displayed using response 
surfaces, which were estimated by the RSM-S based on the original data set. The accuracy of 
each response surface was evaluated by leave-one-out cross-validation (LOOCV), which 
produced correlation coefficients ranging from 0.96 to 0.99. The response surfaces are shown 
in Figure 8. As shown by the response surface (Fig. 8a), hardness increased as the amount of 
CS decreased. A much higher hardness value was observed for tablets containing a low and 
high amount of CS and MCC, respectively. The tablet with a large amount of MCC had a low 
D30, and the others had a high D30 before the accelerated test (Fig. 8c). The response surfaces 
for hardness and D30 were significantly different after the accelerated test compared with 
before the accelerated test. After the accelerated test, the hardness tended to increase and D30 
to decrease (Fig. 8b and d). In particular, D30 changed markedly when the quantity of CS was 
5% to 25% after the accelerated test. 
 
Fig. 8. Response surfaces of the indomethacin tablets estimated by RSM-S as a function 
of the amounts of lactose, cornstarch (CS), and microcrystalline cellulose (MCC). (a) 
and (b) indicate hardness before and after the accelerated test, respectively. (c) and (d) 
indicate the dissolution rate 30 min before and after the accelerated test, respectively. 
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3.2. Setup of the design space for formulation of IMC tablets using RSM-S 
The nonlinear design spaces were defined as >3 kgf hardness and >70% dissolution 30 min 
before and after the accelerated test. Because the hardness tended to increase after the 
accelerated test, the criterion measure of hardness was defined as >3 kgf before the 
accelerated test. By contrast, because D30 tended to decrease after the accelerated test, an 
acceptable range of dissolution, defined as D30 >70%, was desired after the accelerated test. 
 
3.3. Histograms of the design space border 
The reliability of the design space border estimated by RSM-S was evaluated using the 
resampling method. Histograms of 500 resampling borders of the design space for each 
response are shown in Figure 9. When the resampling data included data with a lack, an 
outlier was observed and the data distribution deviated from normal, as shown in Figure 9a 
and c. However, the outliner was diminished when the data with a lack was removed from the 
analysis, as shown in Fig.9b and d. Kurtosis and skewness were estimated as the statistical 
indices to evaluate the normality of the distribution of the design space border determined 
with resampling method. Histogram of design space border as a function of the amount of 
lactose with a step size of 2.32 mg was evaluated and each value was shown as a histograms. 
In each case, both kurtosis and skewness deviated somewhat from 0. The normality of the 
histograms of the border of the design space for each response was tested using the 
Jarque–Bera hypothesis test. The percentages of histograms of hardness and D30 judged to be 
distributed normally were 44.6% and 22.0%, respectively. 
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Fig. 9. Histograms of the borders of the design space estimated by the resampling 
set. Resampling was repeated 500 times. When the resampling set includes a lack of 
one or more formulations, as shown in Figure 6, the relevant set was deleted from 
the analysis. After this tuning of the resampling data, histograms of the border of the 
design space for hardness and dissolution rate at 30 min were made using 353 and 
339 data sets, respectively: (a) hardness and (b) dissolution rate at 30 min. 
3.4. Setup of the conservative design space 
The 95% CIs of the border of the design space were estimated based on the percentile 
technique as a nonparametric approach. The results are shown in Figure 10a and b. The 
conservative and optimistic borders were defined as the 95% CIs of the acceptance ranges of 
the hardness and D30 values. The reliability of the border decreased with departures from the 
center, and the reliability of hardness was lower in the neighborhood of the center than that of 
D30. Two design spaces were superimposed, and a common conservative design space was 
defined as the successful formulation range (Fig. 11). 
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Fig. 11. Conservative design space comprising superimposed individual design spaces for 
hardness and dissolution rate at 30 min for the relevant 95% CIs. 
3.5. Mathematization of the conservative design space 
A polynomial approximation technique was applied for mathematization of the border of 
the nonlinear design space and produced correlation coefficients > 0.99. The conservative 
design space was expressed as the region implemented simultaneously in the following four 
mathematical formulas. 
y > – 3.118 " 10–5x3 + 0.0059x2 – 1.0295x + 118.21  (8) 
Fig. 10. Design space and 95% CIs of the design space border. (a) Hardness >3 kgf and (b) 
dissolution rate >70% at 30 min.
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y < 1.261 × 10–5x3 – 0.0046x2 – 0.5556x + 125.82  (9) 
x, y, z > 0  (10) 
x + y + z = 161 (mg) (11) 
where x, y, and z are the quantities of lactose, MCC, and CS, respectively. 
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4. Discussion 
In this study, tablets comprising mainly lactose, CS, and MCC were prepared. Lactose, CS, 
and MCC were chosen as the filler, disintegrating agent, and binding agent, respectively. The 
response variables such as hardness and D30 were predicted accurately using RSM-S, as 
shown clearly in the results of the LOOCV. Multiple regression analysis was also performed 
and the coefficient of determination which was adjusted with degrees of freedom (R**2), an 
indicator of the fit of each linear regression equation, was estimated. R**2 for hardness was 
approximately 0.90 before and after accelerated test, resulting in relatively high value, but it 
was worse than that of RSM-S. R**2 for D30 was approximately 0.66 before and after 
accelerated test, resulting in poor estimations, better result was observed with RSM-S. 
To consider hardness, dissolution property, and stability, the design space was defined as 
the tablets whose hardness and dissolution rate at 30 min were >3 kgf and 70%, respectively, 
before or after the accelerated test. The shape of either border of the design space changed 
with the quantity of CS. This result suggests that a change in the response induced by the 
change in the CS amount would not be compensated by increasing the amount of lactose and 
MCC. By contrast, the acceptance range of the amount of lactose was larger, suggesting that 
changes attributed to the amount of lactose can be substituted by changes in the amounts of 
CS and MCC. 
Five hundred borders of the design space were generated using the resampling method 
with replacement. Most of the histograms before omitting the data set with a lack had a far 
from normal distribution (Fig. 9a and c), and some showed several peaks. By deleting the data 
with a lack from the resampling set, the shape of the response surfaces estimated by the 
resampling set would be fractured considerably from the original surface.40 For this reason, 
resampling sets with a lack of one or more formulations were removed. After this tuning 
process, about 30% of the resampling data sets were deleted and about 70% remained; the 
remaining data sets were used to evaluate the border of the design space. Moreover, the 
outliers disappeared and most of the histograms after clustering seemed to be symmetrical in 
appearance. To estimate the stability of the reliability of the optimal formulation using the 
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RSM-S and bootstrap resampling method, a resampling frequency of >50 was sufficient.16 
Therefore, 350 resampling sets corresponding to 70% of the total resampling data should be 
sufficient to estimate the reliability of the border of the design space.
To evaluate the robustness of the border of the design space, histograms of the border were 
calculated using the resampling technique. The resampling technique is a statistical interval 
analysis that uses a Monte Carlo simulation. To provide the special benefit of the central limit 
theorem, the shape of the histogram constructed from the arithmetic means of the resampling 
samples follows a normal distribution. It is not possible to hypothesize the central limit 
theorem to the border of the design space derived from RSM-S, so the distribution of the 
resampling design space border must be evaluated. Kurtosis and skewness were used as 
indices of normality to evaluate the shape of the distribution of the resampling border of the 
design space (Fig. 12). 
Fig. 12. Histograms for kurtosis and skewness for the design space border: (a) and 
(b) indicate kurtosis and skewness of the design space border of hardness, 
respectively. (c) and (d) indicate kurtosis and skewness of design space border of 
the dissolution rate at 30 min, respectively. 
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Skewness for hardness was expressed mainly as positive values, and both skewness and 
kurtosis for D30 were negative values. This result suggests that the histograms of the border 
of the design space for hardness had an elongated tail and more data in the right tail than does 
a normal distribution. By contrast, the histogram of the border of the design space for D30 
had an elongated tail at the left, more data in the right tail, and a sharper distribution than does 
a normal distribution. The Jarque–Bera test is a goodness-of-fit test of the deviation of the 
departure from normality based on skewness and kurtosis. In our analysis, six of 10 borders 
were judged to have a nonnormal distribution. When the shape of the histogram is skewed 
significantly, the nonparametric CI of the border is more appropriate for estimating the 
reliability compared with the parametric approach.41 The percentile method is a 
nonparametric method for inferring CIs.42–44 Consequently, we employed the percentile 
method as a nonparametric technique. 
The reliability of the border of the design space decreased when approaching the edge of 
the experiment design. The conservative design space in Figure 11 allows robust range 
formulations of sufficient hardness and dissolution rate relevant to the 95% CIs. This is the 
first study to show that the conservative border of the nonlinear design space can be defined 
clearly as a third-order polynomial function of the amounts of excipients such as lactose, CS, 
and MCC. 
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5. Conclusion 
A resampling method with replacement was applied to evaluating the reliability of the 
border of the design space estimated by RSM-S. The accuracy of the response surfaces was 
elucidated sufficiently, with high correlation coefficients produced in the LOOCV. However, 
the shape of the distribution of the border of the design space generated by the resampling 
method with replacement differed from a normal distribution, and the CI of the border was 
estimated using a nonparametric percentile technique. The conservative border of the design 
space relevant to the 95% CI was defined clearly as a third-order polynomial function of the 
amounts of excipients such a lactose, CS, and MCC. This RSM-S and resampling method 
would be a useful tool for estimating the reliability of the border of the nonlinear design 
space. 
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Chapter 3 
 
Latent structure analysis of the process variables and pharmaceutical 
responses of an orally disintegrating tablet   
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1. Introduction 
In previous Chapter 1 and 2, I demonstrated that BN and RSM-S were potential tool for 
clarifying the relationships between design variables and pharmaceutical responses. 
A key goal of QbD is to identify the most important critical quality attributes (CQAs) and 
to understand their relationships with the product performance.45–46 According to the ICH 
Q8(R2), a CQA is a physical, chemical, biological, or microbiological property or 
characteristic that should be within an appropriate limit, range, or distribution to ensure the 
desired product quality. CQAs are generally associated with the drug substance, excipients, 
intermediates in-process materials, or the drug product. A linkage among the causal factors, 
CQAs and pharmaceutical responses should enable identification and understanding of the 
causal factors and their impact on the CQAs 
Since various unit processes are continued in pharmaceutical manufacturing process, 
intermediates in process have an influence on pharmaceutical characteristics. The 
intermediates of characteristics such as powder and granule could be CQAs. The 
intermediates in process materials rather than design variables were chosen as the causal 
factors for the response variables in order to avoid scale-gap and equipment-gap.47 However, 
the relationships among the variables, intermediates in-process materials, and pharmaceutical 
characteristics are intricate. 
In recent years, orally disintegrating tablets (ODTs) have become popular worldwide. 
ODTs are preferred by an increasing number of patients, especially children and the elderly, 
but also adults who like to have their medication readily available at any time. Various 
compositions and manufacturing methods of orally disintegrating or dissolving tablets have 
been reported.48–50 However, ODTs have several disadvantages: they are generally brittle and 
a special apparatus is needed for their manufacture. Therefore, ODTs are difficult to prepare 
in their final dosage form. 
In this chapter, I optimized the process parameters using RSM-S and determined the 
granule properties that are closely associated with process variables and responses of ODTs. I 
applied a BN to analyze the causal correlations among variables of the manufacturing process, 
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granules, and tablet properties. A BN was used to construct a probabilistic graphical model of 
the latent structure of ODTs and to reveal the latent structure in the manufacture of these 
tablets.  
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2. Materials and methods  
2.1. Materials 
Indomethacin (IMC), which was used as a model drug and magnesium stearate (Mg-St) 
were purchased from Hachidai Pharmaceutical Company, Ltd (Osaka, Japan) and Wako Pure 
Chemical Industries, Ltd (Osaka, Japan), respectively. The δ form of mannitol (Parteck® 
Delta M) was purchased from Merck KGaA (Darmstadt, Germany). Microcrystalline 
cellulose (MCC; Ceolus PH-101, Asahi Kasei Chemicals Co., Ltd, Tokyo, Japan) was gifts 
from Daiichi Sankyo Co., Ltd (Tokyo, Japan). Cross povidone (Cross-PVP; Polyplasdone® 
XL, ISP Co., Ltd, N.J., USA) was a gift from Nippon Shokubai Company, Ltd (Osaka, 
Japan). 
 
2.2. Preparation of ODTs 
Process conditions were fixed according to the flow chart presented in Figure 13. The 
ingredients were accurately weighed according to the experimental formulations and all 
ingredients, with the exception of Mg-St, were blended using a mixer (KM4005, De’Longhi, 
Italy) for 1 min. Distilled water was added as a granulation liquid and the mixture was 
kneaded (impeller speed, 470 rpm; processing time, 1–9 min). After the granulation process, 
the granules were sieved through a 5.8 mm mesh. The granules were dried at 75°C for 30 min 
and sieved through a 850 µm mesh. Mg-St was added to the granules and the mixture was 
blended in a polyethylene bag for 1 min. The final blend was compressed into round-faced 
tablets (200 mg, 8 mm in diameter, with a 12 mm radius of curvature) using a tableting 
machine (Handtab-100, Ichihashi-Seiki Co., Ltd, Kyoto, Japan). All the formulations were 
composed of 25 mg of IMC, 145 mg of δ-mannitol, 20 mg of Cross-PVP, and 10 mg of MCC. 
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Fig. 13. Flow chart of the granulation process. 
2.3. Experimental design 
To develop systematic model formulations, 27 kinds of tablets containing indomethacin, 
%-mannitol, Cross-PVP, MCC, and Mg-St were prepared according to a Box–Behnken design 
(Table 2). Water amount (X1), kneading time (X2), compression force (X3), and amount of 
Mg-St (X4) were selected as the design variables. 
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Table 2. Box–Behnken experimental design of four process parameters and response 
variables. 
Rp. 
Design variables  Response variables 
X1 
(%) 
X2 
(min) 
X3 
(kN) 
X4 
(%) 
 
TS 
(MPa) 
DT 
(s) 
1 30 1 4 1.5  0.85±0.01 9.24±0.06 
2 30 9 4 1.5  1.12±0.03 13.65±0.11 
3 40 1 4 1.5  1.00±0.08 13.76±0.16 
4 40 9 4 1.5  1.28±0.04 15.56±0.15 
5 35 5 3 0.5  0.74±0.00 13.69±0.30 
6 35 5 3 2.5  0.81±0.02 11.33±0.15 
7 35 5 5 0.5  1.42±0.03 14.82±0.08 
8 35 5 5 2.5  1.51±0.08 18.07±0.26 
9 30 5 4 0.5  0.99±0.04 11.27±0.20 
10 30 5 4 2.5  1.10±0.05 12.22±0.20 
11 40 5 4 0.5  1.20±0.07 14.16±0.16 
12 40 5 4 2.5  1.33±0.06 15.80±0.17 
13 35 1 3 1.5  0.68±0.00 8.85±0.11 
14 35 1 5 1.5  1.17±0.06 12.14±0.38 
15 35 9 3 1.5  0.74±0.03 11.53±0.23 
16 35 9 5 1.5  1.47±0.09 15.31±0.22 
17 30 5 3 1.5  0.75±0.00 9.49±0.25 
18 30 5 5 1.5  1.36±0.05 14.72±0.20 
19 40 5 3 1.5  0.94±0.01 12.75±0.25 
20 40 5 5 1.5  1.65±0.06 18.84±0.19 
21 35 1 4 0.5  0.79±0.05 9.55±0.25 
22 35 1 4 2.5  0.91±0.03 11.74±0.25 
23 35 9 4 0.5  1.08±0.02 13.09±0.12 
24 35 9 4 2.5  1.17±0.02 13.31±0.08 
25 35 5 4 1.5  1.16±0.05 12.63±0.21 
26 35 5 4 1.5  1.17±0.05 12.50±0.23 
27 35 5 4 1.5  1.13±0.02 12.71±0.20 
X1 is water amount. X2 is kneading time. X3 is compression force. X4 is amount of 
Mg-St. TS is tensile strength. DT is disintegration time. The value of TS and DT 
represent the mean ± S.D. for three determinations. 
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2.4. Evaluation of tablet properties 
The hardness of the tablets was determined using a tablet hardness tester (Ogawa Seiki Co., 
Tokyo, Japan). Tensile strength (TS) was calculated using Eq. (1). The TS of three tablets of 
each formulation were measured. The disintegration test was performed according to the JP16 
disintegration test for tablets using a disintegration tester (NT-20H; Toyama Sangyo Co., Ltd, 
Osaka, Japan) and water (as a solvent) at 37°C. Disintegration time (DT) was defined as the 
interval required for the complete disappearance of a tablet or its particles from the tester net. 
DT was measured for three tablets of each formulation. The dissolution test was performed 
according to the JP16 dissolution test no. 2 (the paddle method) at 100 rpm (NTR-6100A, 
Toyama Sangyo Co., Ltd, Osaka, Japan). The dissolution medium used was 900 mL of 
mixture of 1 volume of 0.05 M phosphate buffer (pH 7.2) and 4 volumes of distilled water at 
37±0.5°C. The samples were collected and filtered after 5, 10, 15, 20, 25, 30, 40, and 50 min. 
The concentration of indomethacin was measured spectrophotometrically at 320 nm using a 
Jasco Ubest-30 spectrophotometer (Japan Spectroscopic Company, Ltd., Tokyo, Japan). The 
dissolution rates of three tablets of each formulation were measured. 
 
2.5. Physicochemical properties of granules 
Quantities of β-mannitol (Qβ), specific surface area (Sw), and mean size (d50) and relative 
width (Rw = (d10 – d10)/d50) of particles were measured. The Qβ of granules was determined 
via a combination technique using a X-ray powder diffractometer (XRD; RINT-1400 X-ray 
diffractometer, Rigaku, Tokyo, Japan) and a partial least squares (PLS) regression analysis.51 
These measurements were carried out at 40 kV, 40 mA with a CuKα source between 5° and 
30° 2θ with a scan speed of 2.0°/min in the step scan mode. 
The Sw of the granules was measured using the single-point BET method (Macsorb HM 
model-1201, Mountech, Tokyo, Japan). Before measurement, about 1 g of each sample was 
weighed in a sample tube and was then degassed for 30 min at a temperature of 60 °C using 
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nitrogen as the purge gas. Subsequently, the specific surface area of the granules was 
measured using nitrogen adsorption. 
 The d50 and Rw of granules were determined based on the distribution of particle sizes, 
which was measured using a sieving machine (Robot Shifter RPS-105, Seisin Enterprise, 
Tokyo, Japan) using the following sieves: 75, 106, 150, 212, 300, 500 and 800 µm. Samples 
of 10 g were passed through the sieves and stirred during a predefined time of 3 min. Finally, 
the powder fraction held in each sieve was weighed. 
 
2.6. Computer programs 
The nonlinear RSM was performed using dataNESIA® version 3.2 (Yamatake Corporation, 
Fujisawa, Japan). Multiple linear regression analysis was performed using Microsoft Excel® 
for Windows 2007 (Microsoft Corporation, Redmond, WA). A chemometric analysis for 
XRD data was performed using the PLS program associated with the Unscrambler 9.0 
software (Camo Technologies, Woodbridge, NJ). The BayoNet System software, version 5.0. 
(Mathematical Systems Inc., Tokyo, Japan) was used to construct the probabilistic graphical 
model among the variables manufacturing process, granules, and tablet properties and to 
estimate conditional independencies. 
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3. Results 
3.1. Prediction of the responses of tablets using RSM-S 
TS and DT were measured as tablet properties. The response surfaces for each tablet 
property were estimated using RSM-S based on the original data set. The accuracy of the 
response surfaces was evaluated via leave-one-out cross-validation (LOOCV), which revealed 
that the correlation coefficients for TS and DT were sufficiently high (0.977 and 0.979, 
respectively). The response surfaces of the tablet properties are shown in Figure 14. The TS 
increased as the water amount (X1), kneading time (X2), and compression force (X3) increased. 
The amount of Mg-St (X4) had a negligible effect on TS. The DT decreased as X1, X2, X3, and 
X4 decreased. Formulations Rp.13 and Rp.20 showed the lowest and highest value of DT in 
all formulations tested, respectively. Therefore, the dissolution test was performed in the 
limited way to formulations Rp.13 and Rp.20. The dissolution rate at 5 min for IMC from 
formulations Rp.13 and Rp.20 was 93.1±1.7% and 92.1±2.6%, respectively. No significant 
difference was observed between Rp.13 and Rp.20. 
Fig. 14. Response surfaces of orally disintegrating tablets estimated using RSM-S 
based on water amount, kneading time, compression force, and quantity of Mg-St. 
Panels (a) and (b) indicate tensile strength and disintegrating time, respectively. 
3.2. Optimization of process variables using RSM-S 
The process variables of tablets were optimized using RSM-S based on the original data 
set. The optimization problem was formulated to maximize TS and to minimize DT with an 
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even weight within the range of experimental space. Results of the simultaneous optimum 
analysis are given in Table 3. The water amount (X1) = 30.57%, kneading time (X2) = 3.16 
min, compression force (X3) = 4.04 kN, and the amount of Mg-St (X4) = 1.45% were estimated 
as the optimal process variables. The following were estimated as the optimal response 
variables: TS = 0.98 MPa and DT = 10.72 s. Table 3 also shows the TS and DT of the optimal 
process variables. The TS and DT values predicted by RSM-S coincided well with the 
experimental values. 
 
 
Table 3. Predicted and experimental values of response variables of 
optimal process variables based on the RSM-S. 
 Predicted Experimental 
Water amount (%) 30.57 – 
Kneading time (min) 3.16 – 
Compression force (kN) 4.04 – 
Mg-St (%) 1.45 – 
Tensile strength (MPa) 0.98 1.01±0.03 
Disintegration time (s) 10.72 10.80±0.40 
 
3.3. Prediction of granule properties using RSM-S 
Qβ, Sw, d50, and Rw were measured as granule properties. The response surfaces for each 
granule property were estimated using RSM-S based on the original data set. The accuracy of 
the response surfaces was evaluated by LOOCV, which revealed that the correlation 
coefficients for Qβ, Sw, d50, and Rw were sufficiently high (0.935, 0.929, 0.899, and 0.885, 
respectively). The analysis of response surfaces showed that the Qβ and granules increased 
with increasing kneading time (X2); however, water amount (X1) had only a small effect on Qβ. 
Sw increased with increasing water amount (X1) and kneading time (X2). d50 was highest for 
high water amounts (X1) and short kneading times (X2). In contrast, Rw was highest for small 
water amounts (X1) and long kneading times (X2) (Figure 15). 
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Fig. 15. Response surfaces of granule properties estimated using RSM-S based on 
water amount and kneading time. (a) Amount of !-mannitol, (b) specific surface 
area, (c) mean particle size, and (d) relative width. 
3.4. Estimation of a quantitative latent structure model using a Bayesian network 
An analysis of the causal relationships among process variables and granule and tablet 
properties was used to estimate the latent structure model using a BN. All variables were 
discretized to three levels for the inference of the conditional probability distribution. The 
optimal BN models were predicted using Akaike’s information criterion (AIC), the K2 
algorithm, and minimum description length (MDL) as the judging standards. The accuracy, 
precision, recall, and F-measure of the BN models were evaluated (Figure 16). The BN 
models obtained based on the K2 algorithm (Figure 17) were the highest for all parameters. Q! 
was affected by kneading time (X2) and had an effect on all granule properties. Sw was 
affected by water amount (X1) and kneading time (X2) and had an effect on all tablet 
properties. No links from the node of the amount of Mg-St (X4) were observed. 
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Fig. 16. Bayesian network model of the latent structure among process 
parameters, granule properties, and responses of tablets estimated using the 
K2 algorithm. 
Fig. 17. Four standard measures of Bayesian network models based on each 
measurement criterion. 
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3.5. Evaluation of the causal relationships underlying the latent structure via probabilistic 
inference using a Bayesian network 
Using BN modeling, the posterior probability of the causal factors was also predicted by 
conditional probability distributions (CPDs). To clarify the effects on Q!, the posterior 
probabilities of the causal factors were predicted from Q! and compression force (X3). The BN 
model inferred factors with a short kneading time (X2), low Sw, middle D50, intermediate Rw, 
low TS, and short DT for tablets with an intermediate compression force (X3) and a low Q!. 
Conversely, the BN model inferred factors with an intermediate kneading time (X2), high Sw, 
low D50, high Rw, intermediate TS, and intermediate DT for tablets with an intermediate 
compression (X3) force and a high Q! (Figure 18). 
 
Fig. 18. Conditional probability distributions (CPDs) of causal factors inferred using a 
Bayesian network model. Compression pressure and amount of !-mannitol were set as 
prior probabilities. The CPDs of the causal factors were estimated for two cases: 
intermediate compression force and low amount of !-mannitol, and intermediate 
compression force and high amount of !-mannitol. 
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4. Discussion 
In this study, tablets containing mainly mannitol, Cross-PVP, and MCC were prepared. 
Mannitol, Cross-PVP, and MCC were chosen as the filler, the disintegrating, and the binding 
agents, respectively. 
Generally, ODTs are produced using a particular manufacturing method. Recently, it was 
reported that ODTs were also produced by a wet-granulation process using a polymorphic 
transition from the δ to the β form of mannitol.52-53 In this study, we applied this technique to 
prepare ODTs. 
We selected the amount of water (X1) (as the granulation liquid), kneading time (X2), 
compression force (X3), and amount of Mg-St (X4) as design variables. Water amount (X1) and 
kneading time (X2) may influence granule properties, such as Qβ, Sw, d50, and Rw, and have an 
indirect impact on tablet properties. Conversely, compression force (X3) and amount of Mg-St 
(X4) may also have a direct effect on tablet properties. When the water amount (X1) reached 
~45%, we could not prepare granules; therefore, the upper limit of the water amount (X1) was 
set at 40%. A dissolution test revealed an absence of significant differences between Rp.13 
and Rp.20. In contrast, Rp.13 and Rp.20 exhibited the lowest and longest disintegration times, 
respectively. This result suggests that all formulations tested have an excellent dissolution 
property. Therefore, we did not perform dissolution tests for the other formulations. 
Response variables, such as Qβ, Sw, d50, Rw, TS, and DT, were predicted accurately using 
RSM-S, as shown clearly by the results of the LOOCV. Multiple regression analysis was also 
performed and the coefficient of determination, which was adjusted with degrees of freedom 
(R**2) and is an indicator of the fit of each linear regression equation, was estimated. The R**2 
values for Qβ, Sw, d50, Rw, TS, and DT were 0.712, 0.736, 0.747, 0.89, 0.861, and 0.699, 
respectively, resulting in poor estimations; a better result was observed using RSM-S. 
The RSM is used widely to visualize the relationships between causal factors and 
responses. However, this method is limited to the three-dimensional (3D) space and includes 
basic information about the relationship between only two limited factors and one response. 
The Hyper-Dimensionally Embedded Cuboids (hyperDEC) technique has been developed as 
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a novel approach to visualize multivariable relationships. This method overcomes the 
limitation of the contour plots of 3D surface plots, which cannot display simultaneously the 
effects of more than two variables.54 Using an approach similar to hyperDEC, we were able to 
viscerally and quantitatively understand the relationships between causal factors and 
responses (Figure 14). Both TS and DT increased with increasing water amount (X1), 
kneading time (X2), and compression force (X3). TS surface was similar to DT, indicating that 
TS and DT were trade-off. 
The relationship between two design variables and granule properties were clarified using 
RSM-S (Figure 15). Figure 15a suggests that a polymorphic transition from the δ to the β 
form of mannitol was induced by the wet-granulation process. A concomitant morphological 
change resulted in an agglomerate consisting of filament-like fine primary crystals (δ-granule). 
This phenomenon gave rise to an increase in Sw. Therefore, the Qβ surface was similar to the 
Sw, indicating that Qβ has a strong influence on Sw. Because Sw was affected not only by Qβ but 
also by water amount (X1), kneading time (X2), and d50, the response surface for the Sw was 
barely different from Qβ.  
BNs efficiently implement the probabilistic inference algorithm, which estimates the 
probability distribution of arbitrary random variables in a model.55 To analyze the latent 
structure among causal factors, granule properties, and responses in ODTs, BN models were 
constructed using AIC, the K2 algorithm, and MDL as the judging criteria. The internal 
structures of BN models differed slightly depending on the judging criteria. Therefore, the 
optimal BN model was estimated using the indices accuracy rate, precision, recall, and 
F-measure (Figure 16). In general, there is a trade-off between precision and recall, as greater 
precision decreases recall and vice versa. The F-measure is the harmonic mean of precision 
and recall and considers both measures. All measures estimated using the model based on the 
K2 algorithm were more than 90% accurate, indicating that the prediction ability of the 
probabilistic model is sufficiently high. In contrast, all measures estimated using the model 
based on AIC and MDL were less than 90% accurate (Figure 16). 
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The distinctive probabilistic model was estimated by the edges, which represent 
conditional dependencies, and between the nodes, which represent the variables. The use of a 
BN model allowed the thorough understanding of the relationships among the variables of the 
manufacturing process and granule and tablet properties (Figure 17). As usual, TS and DT are 
strongly affected by the amount of Mg-St. However, no links between Mg-St (X4) and TS or 
DT were observed, as shown in Figure 17. As shown in Figure 14, the effect of X4 on TS and 
DT was rather weak compared with that of the other factors. This may be due to the limited 
amounts of Mg-St, which were ≤ 2.5%. Another explanation is that the powder sample used 
to prepare granules was small (200 g) in this study. It is well known that the lubricant effect 
of Mg-St is dependent on the scale of the samples. 
Although Sw, d50, and Rw were mutually dependent, in general, the BN model showed no 
significant effect of d50 and Rw on TS and DT. This result indicates that Sw is selected as a 
representative of granule parameters, such as d50 and Rw. 
The CPDs of the factors of the ODTs were predicted using the BN model. The posterior 
probabilities of the factors for intermediate compression force and high and low Qβ were 
appropriately estimated (Figure 18). The BN model was able to estimate not only the effects 
of the causal factors on each response, but also the trends in the responses produced by the 
formulations as CPDs. 
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5. Conclusion 
In this study, ODTs composed of IMC, mannitol, Cross-PVP, and MCC were prepared. 
The robustness of the response surfaces estimated via RSM-S was elucidated sufficiently, 
with high correlation coefficients observed in LOOCV. Optimal process variables were 
predicted quantitatively using RSM-S. Moreover, a latent structure analysis based on the 
variables of manufacturing process and granule and tablet properties was performed using BN. 
We visualized clearly the nonlinear relationships among the variables and identified several 
important correlations among them. 
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Chapter 4 
 
Prediction of tablet characteristics from residual stress distribution 
estimated by the finite element method 
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1. Introduction 
In previous chapters, I applied statistical techniques to pharmaceutical design. However, 
the mechanistic understanding of pharmaceutical unit operations is limited. In this chapter, I 
tried to apply numerical investigation to understand tableting process based on physical 
phenomenon. 
Numerical investigation of the tableting process can assist in providing an understanding 
of the influence of tooling properties, lubrication and compaction kinematics (e.g., 
compaction speed and compaction sequences), and provide guidance for the optimization of 
tooling design and the improvement of powder formulation. One numerical analysis method 
is the finite element method (FEM), which is well established for the modeling of 
deformation of powders in various industries, such as compaction in ceramic industries, and 
analyzing pharmaceutical powder compaction.56–57 In the FEM, powders are modeled as 
continuum media and the compaction behavior is analyzed by solving boundary value 
problems. 
The Drucker–Prager Cap (DPC) model is one of the continuum mechanical models, in 
which the powder is considered a porous medium. The DPC model can represent the 
densification and hardening of the powder, as well as the interparticle friction.58–59 The DPC 
model is therefore frequently used to analyze the strain, relative density changes and stress 
distribution of tablets during the tableting process.60–62 The DPC model is characterized by 
parameters such as cohesion, internal friction angle, Young’s modulus, Poisson ratio, 
parameters related to volume change and hardening mechanisms, and so on. In general, full 
calibration of the DPC model requires triaxial, hydrostatic compression and proportional 
loading tests. These tests are commonly used for metallurgical powders.63–64 Because 
pharmaceutical powders are very soft and loosely packed, the application of triaxial cells in 
pharmaceutical materials is difficult. A shear cell test, which is based on the Mohr–Coulomb 
failure criterion, supplies data on the powder’s cohesion and the friction angle at different 
pressures.65–66 A direct shear test could also supply data on the cohesion and friction angle 
based on the Mohr–Coulomb failure criterion. In this study, volume change and hardening 
 56 
 
law parameters were estimated using a response surface method that incorporated multivariate 
spline interpolation (RSM-S). 
Several studies have reported that the residual stress distribution of tablets was estimated 
using the FEM, in which the powder is modeled using the DPC model. For instance, Han et al. 
have reported that density distributions of tablets were affected by punch geometry.67 Tablet 
failure, in particular capping, is more likely to be associated with an intensive shear band 
formed during the decompression stage.68–69 It has been shown that the density distribution 
patterns are comparable with the experimental results of others.70–74 
The residual stress distribution of tablets might be affected by formulation and process 
variables. However, in the past, the influence of the residual stress distribution of tablets on 
characteristics of tensile strength (TS) and disintegration time (DT) has not been determined. 
The aim of this chapter was therefore to reveal differences in stress distribution between 
tablets composed of various formulations. Moreover, the predictive abilities of tablet 
characteristics of TS and DT on residual stress distribution were investigated. 
Multiple linear regression analysis (MRA) and partial least squares (PLS) regressions were 
applied to determine the quantitative relationships between the stress distribution of tablets 
and the characteristics of TS and DT. 
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2. Materials and methods  
2.1. Materials 
Lactose (LAC; Tablettose 80, Meggle Japan Co. Ltd, Tokyo, Japan), cornstarch (CS; 
Graflow M, Nippon Starch Chemical Co. Ltd, Osaka, Japan) and microcrystalline cellulose 
(MCC; Ceolus PH-101, Asahi Kasei Chemicals Co. Ltd, Tokyo, Japan) were purchased. 
Magnesium stearate (Mg-St) was purchased from Wako Pure Chemical Industries Ltd (Osaka, 
Japan). LAC, CS, MCC and Mg-St were chosen as the filling, disintegrating, binding and 
lubricating agents, respectively. 
 
2.2. Simulated conditions of the tableting process 
Because the compaction of cylindrical tablets is an axisymmetric case, it can be analyzed 
using a two-dimensional FEM. Figure 19 shows the flow of the FEM; i.e., a FEM for 
modeling the compaction of flat-faced tablets, the model at the point of maximum 
compression and the model during decompression. The powder was exhibited as a DPC 
model. The die wall and upper punches were modeled as rigid bodies. The interaction 
between the powder, die wall and upper punch was modeled and the friction in the contacts 
was set to 0.195, in accordance with the reference.19 The nodes on the symmetry axis were 
restricted to move only horizontally, and the nodes at the bottom boundaries were allowed to 
move only vertically. The upper punch could move vertically with compression. 
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Fig. 19. Flow chart of the finite element analysis: a typical finite element model for 
modeling the compaction of flat-faced tablets, the model at the point of maximum 
compression and the model during decompression. The powder was modeled using the DPC 
model. An axisymmetric two-dimensional model (right half) was used. 
 
2.3. DPC model 
The DPC model was originally developed to predict the plastic deformation of soils under 
compression.6–7 The model is formulated in terms of two invariants, !!, the first invariant of 
the Cauchy stress, and J2, the second invariant of the deviator stress. In terms of principal 
stresses, these invariants are given as: 
!! ! !! ! !! ! !! (12) 
!! !
!
!
!! ! !! ! ! !! ! !! ! ! !! ! !! !  (13) 
where !!, !! and !! are the maximum, intermediate and minimum principal stresses, 
respectively, and compression is taken as negative. 
Figure 20 shows the yield surface of the DPC model. It consists principally of three 
intersecting portions: a shear failure segment Ys, a cap segment Yc, and an expansion envelope 
portion Yt, respectively. A typical geometrical shear envelope function is based on the 
exponential format given as: 
!! !!!!! ! !! ! !! !
!!! ! !!!! (14) 
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where σ0 is the current cohesion related to a material constant. A, 𝛽! and 𝛼! are shear 
failure parameters. In this study, A and 𝛽! were regarded as zero and the shear failure was 
represented as a simple linear model. 
The cap segment that intersects the equivalent pressure stress axis is an elliptical curve 
with constant eccentricity in the l1–J2 plane, as given by: 𝑌! 𝑙!,𝐾!,𝜎! = 1− 𝐻 𝐾! − 𝑙! !!!!!!!!!! !!,!! ! (15) 
where H is the Heaviside (or unit step) function. 𝑅!! is the ratio of elliptical x-axis to 
y-axis (l1 to J2). K0 is the key flag, indicating the current transition point at which the 
compaction cap surface and shear portion intersect. 
The expansion cap function Yt is an elliptical function combined with the Heaviside 
function designed for the expansion cap, and is given by: 𝑌! 𝑙!,𝜎! = 1− 𝐻 𝑙! !!!!!!! !,!! ! (16) 
where 𝑅!! is the ratio of elliptical x-axis to y-axis (l1 to J2). 
The cap hardening law is defined by describing the evolution of the parameter X0, the 
intersection point of the compaction cap and the l1 axis. The evolution of X0 is related only to 
the plastic volume strain. The typical cap hardening law has the exponential form proposed by 
Fossum and Fredrich.75 𝜀!! = 𝑤!! 𝑒 !!!!!!! !!!!! !!!!! − 1  (17) 
where Xi is the initial value of X0 at which the cap takes effect in the plasticity model. 𝑊!! 
is the maximum possible plastic volumetric strain for geomaterials. Parameters 𝐷!! and 𝐷!! 
have units of 1/MPa and 1/MPa2, respectively. In this study, 𝐷!! was regarded as zero and the 
hardening law was regarded as the simple model. 
Moreover, the DPC model contains three parameters: Young’s modules (E), the Poisson 
rate (υ) and the parameter related to the ratio of triaxial extension strength to compression 
strength (ϕ). When ?= 0, a yielding surface indicates the von Mises yield criterion. 
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Fig. 20. A yield surface of the DPC model. The DPC model consists 
principally of three intersecting portions: an expansion envelope portion (Yt), a 
shear failure segment (Ys) and a cap segment (Yc). In this study, a shear failure 
is regarded as a simple linear model. 
 
2.4. Screening of DPC model parameters 
A fractional factorial experimental design was used to evaluate the relative contributions of 
DPC model parameters. E, $, !!
!, !!
!, Xi, #i, !!, %, !!! !!"#! !! !were selected as the causal 
factors affecting outputs such as volume change and maximum equivalent stress. One 
hundred twenty-eight kinds of DPC models were constructed. Levels in coded form and the 
exposition of each causal factor are summarized in Table 4. The constructed DPC model was 
fed into the analysis and the mechanical behavior of the powders during compaction was 
simulated using the FEM. To evaluate the significance of causal factors and their interactions, 
the data estimated using the FEM results were analyzed by analysis of variance (ANOVA). 
 
Table 4. Level in coded form in ANOVA and exposition of each DPC model parameter 
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Independent variables 
(DPC model parameters) 
Level in coded form
1 2 
E : Young’s modules (GPa) 3 4 
$ : Poisson rate 0.1 0.2 
!!
!  : Ratio of l1 to J2 in compression 0.5 0.7 
!!
!  : Ratio of l1 to J2 in tension 10 15 
Xi : Initial value of cap intersection with l1 (–0.8e–3) " 3 (–1e–3) " 3 
#i : Parameter for initial cohesion value (8e–4)/ ! (1e–3)/ ! 
& y : Linear term for shear envelope 38 42 
" : 
Ratio of triaxial extension strength to compression 
strength 
0.98 1 
!!
!  : Max possible plastic volumetric strain 0.475 0.525 
!!
!  : Cap hardening exponential term (units 1/MPa) 0.003 0.004 
 
 
2.5. Preparation of model formulations 
Model tablet formulations are shown in Fig. 21. Various amounts of LAC, CS, and MCC 
were selected as the formulation factors. Based on preliminary experiments, the lower and 
upper limits of the levels of each factor were set. 
 
Fig. 21. Six model formulations composed of LAC, CS and MCC. LAC, CS and MCC 
were chosen as the filler, the disintegrating and the binding agents, respectively. Each 
number indicates formulation numbers, respectively. 
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2.6. Measurement of a failure envelope using the direct shear test 
A direct shear tester (NS-V100, Nanoseeds Corporation, Gifu, Japan) was used to measure 
the failure envelope and estimate the two DPC model parameters of 𝛼! and σ!. Before 
measurement, all ingredients were dried at 75°C for 12 h. Powder (20 g) was added into the 
shear cell. Precompression was performed consecutively at 50 and 45 N. Shear stresses were 
then measured when the powder bed was compressed at 20, 30 and 40 N, respectively. Data 
observed were plotted in the axial shear (𝜎)-stress (𝜏) plane. The linear approximation method 
was applied to estimate a failure envelope. The failure envelope was measured for six 
powders of each formulation. 
To obtain the internal friction angle (𝛼!) and cohesion (𝜎!) in the equivalent stress 
(p)–hydrostatic stress (q) plane, a Mohr’s circle that touched the failure envelope in the 𝜎–𝜏 
plane was estimated (Fig. 22). Two intersections between the Mohr’s circle and the x-axis 
were then calculated. These values indicate the maximum and minimum principal stress (𝜎! 
and 𝜎!) in triaxial compression status, respectively: 
 𝜎! = !!!!!! − !!!!!! sin𝜃  (18) 
 𝜏! = !!!!!! cos𝜃 (19) 
where 𝜎! and 𝜏! are the points on the failure envelope, and 𝜃 is the internal friction 
angle in the 𝜎–𝜏 plane. 
For this study of the direct shear test, using uniaxial compaction in a cylindrical die in the 
z-direction, the following assumptions can be made: 
 𝜎! = 𝜎! (20) 
 𝜎! = 𝜎! = 𝜎! (21) 
We therefore have: 𝑝 = !!!!!!!  (22) 𝑞 = !!!!!!  (23) 
Data observed were plotted in the p–q plane and a linear approximation method was 
applied to estimate the failure envelope. The gradient and y–intercept of the failure envelope 
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indicated the internal friction angle !! and cohesion di in the p–q plane, respectively. !! 
and !! are defined as: 
!! !
! !"#!!
!
 (24) 
 !! !
!!!
!!
!
 (25) 
 
Fig. 22. Mohr’s circle contacted failure envelope in the axial–shear stress plane. The maximum and 
minimum principal stresses were estimated from two intersections between the Mohr’s circle and the 
x-axis. 
 
2.7. Preparation of tablets 
All ingredients were dried at 75°C for 12 h. The ingredients were weighed accurately 
according to the experimental formulations, and all ingredients were blended in a 
polyethylene bag for 2 min. The final blend was compressed directly into flat-faced tablets 
(200 mg, 8 mm diameter) using a tableting machine (AUTOTAB-500; Ichihashi-Seiki 
Company Ltd, Kyoto, Japan). All formulations comprised 198 mg of a mixture of LAC, CS, 
and MCC, and 2 mg of Mg-St. 
2.8. Estimation of DPC model parameters using volume change as output 
A statistical method was applied to estimating the two DPC model parameters (!!! and 
!!
!) using volume change as an indicator. Tablets compressed at 4, 5, 6, 7, 8, 9 and 10 kN 
were prepared and the thickness of tablets was measured. The !!! and !!! were assigned to 
32 full factorial designs, and nine kinds of DPC models were constructed for each formulation. 
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The range of these parameters was determined by a preliminary test. Values of 𝛼! and σi 
were obtained from the direct shear test measurements. E, υ and 𝑅!! were determined based 
on references 19; i.e., E = 3.57 GPa, υ = 0.12 and 𝑅!! = 0.6. 𝑅!! = 10, Xi = 0.1 and ϕ = 1 
were set as arbitrary values, which do not cause divergence problems in FEM analysis. The 
tableting process was simulated using the FEM and measured the thickness of tablets after 
decompression at each compression force. Data observed were modeled by RSM-S, and DPC 
model parameters correlated with the experiment were estimated. 
2.9. Measurement of hardness and DT 
The hardness of the tablets was determined using a tablet hardness tester (Ogawa Seiki Co., 
Tokyo, Japan). TS was calculated using Eq. (1). TS values for six tablets of each formulation 
were measured. 
The disintegration test was performed according to the JP16 disintegration test for tablets 
using a disintegration tester (NT-20H; Toyama Sangyo Co. Ltd, Osaka, Japan) and water (as a 
test medium) at 37°C. The DT was defined as the interval required for the complete 
disappearance of a tablet or its particles from the tester net. The DT was measured for six 
tablets of each formulation. 
 
2.10. Modeling of causal relationships between residual stress distribution and tablet 
characteristics 
MRA was performed to clarify causal relationships between the residual stress distribution 
of tablets and responses of the tablet. Nine typical points of the stress distribution of tablets 
were selected as explaining variables. The TS and DT were selected as responses of tablets. A 
forward selection method based on stepwise selection was applied to the selection of causal 
factors and factors showing p values larger than 0.25 were successively excluded from 
analysis. 
A PLS regression was used to examine the relationships in more detail. PLS calibration 
models were evaluated using the leave-one-out cross-validation (LOOCV) method. Data 
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composed of x-axial, y-axial or shear stress distributions were selected as explaining variables. 
Each stress distribution contained 1532 data points. The TS and DT of tablets compressed at 5, 
7 or 9 kN were selected as output variables. Thirty-six samples in total were used for PLS 
regression analysis in each model. The optimum number of factors was taken to be that 
leading to a minimum value in the predicted residual error sum of squares (PRESS) versus a 
PLS component graph, the former being defined as: 𝑃𝑅𝐸𝑆𝑆 = (𝑦! − 𝑦!)!!!!!  (24) 
where 𝑦! and yi correspond to the TS or DT values of each sample predicted by the 
residual stress distribution and experiment, respectively. 
The goodness of calibration and prediction was assessed in terms of the root mean square 
error (RMSE), which was termed RMSEC for calibration and RMSEP for prediction: RMSE = (!!!!!)!!!!! ! . (25) 
 
2.11. Computer programs 
The FEM analysis of the tableting process was performed using ANSYS® 13.0 (ANSYS 
Inc., Canonsburg, PA, USA). The RSM-S was performed using dataNESIA® version 3.2 
(Azbil Corporation, Fujisawa, Japan). The ANOVA and MRA were performed using JMP 
version 8 (SAS Institute Inc., Cary, NC, USA). The chemometric analysis was performed 
using the PLS regression program associated with the Unscrambler 9.0 software (CAMO 
Technologies, Inc., Woodbridge, NJ, USA). 
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3. Results and discussion 
3.1. Screening of DPC model parameters 
The ANOVA was performed to investigate the influence of DPC model parameters on the 
volume change and stress distribution of tablets. As shown in Table 4, the ranges of each of 
the DPC model parameters were decided based on the previous literature.19 Values of 
parameters were set with a relatively small range because values that are too high or too low 
may cause divergence of iterative calculations. Results of the ANOVA revealed that 15 and 
14 factors significantly affect the volume change (tablet thickness) and the residual stress of 
the tablets, respectively. These results are shown in Tables 5 and 6. The volume change and 
hardening law were significantly affected by 𝑊!!   and  𝐷!!, and the residual stress of tablets 
was significantly affected by the internal friction angle (α y) and Young’s modules (E). The 
hardening law in the DPC model generally refers to the evolution of the cap surface with the 
volumetric plastic strain defined. The 𝑊!! and 𝐷!! are parameters related to the volumetric 
plastic strain. The E and α y parameters are related to elastic deformation and internal friction 
of powder, respectively. 
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Table 5. ANOVA results for tablet thickness 
Factor/Interaction F value p value 𝑊!!  213507 < 0.0001* 𝐷!!  119816 < 0.0001* 
E 30866 < 0.0001* 
α y 10885 < 0.0001* 
ϕ 707 < 0.0001* 
E × α y 629 < 0.0001* 𝑅!! 605 < 0.0001* 
α y × 𝑊!!  69 < 0.0001* 
E × 𝐷!!  67 < 0.0001* 
E × 𝑊!!  61 < 0.0001* 
Wc1 × 𝐷!!  44 < 0.0001* 
E × 𝑅!!  42 < 0.0001* 𝑅!! × α y 37 < 0.0001* 𝑅!! × 𝐷!!  18 < 0.0001* 
E × ϕ 10 0.0021* 
 
Table 6. ANOVA results for equivalent stress 
Factor/Interaction F value p value 
α y 2285 < 0.0001* 
E 2239 < 0.0001* 
E × α y 672 < 0.0001* 𝑊!!  220 < 0.0001* 𝑅!!  141 < 0.0001* 
ϕ 138 < 0.0001* 
α y × ϕ 32 < 0.0001* 
α y × 𝐷!!  27 < 0.0001* 
E × 𝑅!!  19 < 0.0001* 
E × 𝐷!!  16 0.0002* 
E × 𝑊!!  11 0.0012* 𝑊!! × 𝐷!!  6 0.0154* 𝐷!!  6 0.0211* 𝑅!! × 𝑊!!  5 0.0225* 
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3.2. Measurement of the internal friction angle and cohesion 
Figure 23 shows the results of the internal friction angle and cohesion in the 𝜎–𝜏 plane. 
The α y and σi values were found to vary from 4° to 47° and 0.78 kPa to 11.5 kPa, 
respectively. The internal friction angle increased as the amount of MCC increased. The tablet 
with the largest amount of MCC (Rp. 3, 4 and 5) showed the highest internal friction angle 
value. In contrast, the powder composed of only CS and LAC (Rp. 1) had the lowest internal 
friction angle value. The tablet with the largest amount of MCC (Rp. 4) showed the highest 
value of cohesion. On the other hand, the tablet composed of only CS and MCC (Rp. 3) 
showed the lowest value of cohesion. The values of α y and σi were similar to those of the 
failure envelope in the 𝜎–𝜏 plane. 
The effect of the E value on the residual stress distribution was comparable to α y, as 
shown in Table 6. Parameter values in the ANOVA were set with a relatively small range 
because values that are too high or too low may cause divergence of iterative calculations. 
The α y, in particular, causes divergence of iterative calculations. However, although the α y 
value was set from 38° to 42° in the ANOVA, the α y was found to vary from 4° to 47° by 
direct shear test. On the other hand, it is likely that the E value varied from 1 to 6, at most. For 
example, the E value of lactose compressed at 200 and 250 MPa showed 3.5 and 4.6 GPa, 
respectively.59, 65 The E value of the mixture composed of lactose, cornstarch and MCC at 100 
MPa varied from approximately 0.1 to 1.5 GPa.76 The results of the direct shear test and the 
range of parameters suggested that the residual stress might be strongly affected by α y, so E 
was set as a constant. 
 
 
 69 
 
Fig. 23. Results of a direct shear test: (a) the internal friction angle and (b) the cohesion of 
each model formulation. 
 
3.3. Estimation of the hardening law parameters using volume change 
The combined technique of a factorial experimental design and RSM-S was applied to 
determine the volume change and hardening law parameters (!!! and !!!). The volume of 
each formulation weighing 200 mg is shown in Table 7. The powder composed of only the 
CS and MCC (Rp. 3) showed the highest bulk density. In contrast, the powder composed of 
only the CS and LAC (Rp. 1) had the lowest bulk density. 
The thickness of tablets varied from 3.41 mm to 3.84 mm, and from 3.25 mm to 2.96 mm 
when tablets were compressed at 4 kN and 10 kN, respectively. When the compression force 
was 4 kN, the thickness was in the order of Rp. 3 > Rp. 2 > Rp. 6 > Rp. 4 > Rp. 5 > Rp. 1. In 
contrast, the thickness at 10 kN was in the order of Rp. 3 > Rp. 2 > Rp. 1 > Rp. 6 > Rp. 4 > 
Rp. 5. 
Tablet thickness was accurately predicted by the DPC model parameters (!!! and !!!) 
using RSM-S, further suggesting that tablet thickness decreased with increasing !!! and !!!. 
The optimum DPC model parameters are summarized in Table 7. To validate the optimum 
DPC model parameters, the tableting process was simulated using the FEM. The tablet 
thickness simulated by the FEM was compared with experimental values, indicating a good 
linear relation with sufficiently high correlation coefficients from .94 to .98. Moreover, the 
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RMSE values ranged from .01 to .03, indicating sufficiently low prediction error. This result 
suggests that 𝑊!! and 𝐷!! correlated well with tablet thickness. 
 
Table 7. DPC model parameters determined by experiments 
Rp. 
Thickness of 
powder bed 
(mm) 
α y σi 𝑊!!  𝐷!!  
1 6.560 4.352 4.283 0.699 0.010 
2 8.636 22.187 1.545 0.967 0.011 
3 9.626 44.621 0.782 1.083 0.012 
4 9.458 47.807 11.573 1.129 0.015 
5 8.090 45.408 6.995 0.990 0.012 
6 8.301 33.956 1.070 0.997 0.011 
 
3.4. Simulation of the tableting process and estimation of the residual stress distribution of 
tablets 
The material properties calibrated from experiments were fed into the ANSYS software in 
which the DPC model was implemented. The DPC model parameters are shown in Table 4. In 
this study, appropriate values of the parameters E, ν, 𝑅!!, 𝑅!!, Xi and ϕ were sought in an 
arbitrary manner when they could not be measured by the data. 
Although the residual stress distribution was accurately estimated using the DPC-based 
FEM 2D model, there are limitations of applying a two-dimensional FEM to an asymmetrical 
model, such as a caplet or stamped tablet. 
Figure 24 shows a typical residual stress distribution of tablets. In x axial stress (𝜎!), the 
top corner had the highest value while the bottom had the lowest. It is clear that the absolute 
value of y axial stress  (𝜎!) at the top was generally lower than that at the bottom. Moreover, 
the 𝜎! value at the top had the stress extending upward while the bottom had the stress 
extending downward. When the applied force from the upper punch was removed, a large 𝜎! 
value at the top central region was brought about by radial elastic recovery, while most of the 
other regions were still constrained by die walls. At the same time, the  𝜎! value became 
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enlarged at the top central and bottom peripheral regions. Results of the shear stress (𝜏) 
revealed that an intensive shear region was recognized from the top edge to the mid-center. In 
this shear region, the shear stress changed from positive to negative, indicating a change in 
the direction of the shear stress. For instance, when the applied force from the upper punch 
was removed, the radial elastic recovery of the material at the top central region caused large 
shear stresses because most of the other regions were still constrained by die walls, and 
therefore the axial and shear stresses at the top corner of the tablets were larger than those in 
peripheral regions. This result is consistent with previous findings.77 
Although the residual stress distribution is similar among model formulations, the ranges 
of stress values were significantly different. For instance, σ!, σ! and 𝜏 values of the Rp. 2 
were higher than those of the other formulation. The large 𝜏 values were located near the die 
edge in Rp. 2, although the value was rather uniform in the other formulations. In general, 
shear deformation in granules is induced by the dilation of materials. Eccentrically located 
stress in the tablet may cause edge chipping, capping and lamination failure. These have been 
demonstrated experimentally as typical failure patterns in the tableting process.20 It is likely 
that the tablet made by Rp. 2 had such tableting problems. 
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Fig. 24. Two-dimensional maps for the residual stress distribution of tablets estimated using 
the FEM: (a) x axial stress (!!!, (b) y axial stress (!!! and (c) shear stress !!! of Rp. 2. (d) x
axial stress (!!!, (e) y axial stress (!!!!and (f) shear stress!!!! of Rp. 4. 
 
3.5. TS and DT results 
TS and DT were displayed using response surfaces, which were estimated by RSM-S. The 
accuracy of each response surface was evaluated by LOOCV, and correlation coefficients for 
prediction were sufficiently high (.90 to .97). Response surfaces of the TS and DT of tablets 
compressed at 9 kN are shown in Fig. 25. The TS increased as the amount of CS decreased 
(Fig. 25a). A much higher TS value was observed for tablets containing low and high 
amounts of CS and MCC. The tablets with the largest amount of MCC, and with no MCC, 
exhibited high value of DT, while other tablets showed low value of DT (Fig. 25b). 
DT increased with increasing TS. However, the tablet composed of only CS and LAC 
resulted in exceptionally high DT but low TS, indicating that MCC acts not only as a binder, 
but also as a disintegration agent. 
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Fig. 25. Response surfaces estimated by RSM-S for (a) TS and (b) DT of tablets compressed 
at 9 kN. 
3.6. Prediction of tablet characteristics based on the residual stress distribution of tablets
MRA was used to clarify the relationship between the residual stress distribution and tablet 
characteristics. The forward selection method, based on a stepwise selection, revealed that TS 
and DT were affected significantly by 16 and 15 factors, respectively. A coefficient of 
determination, which was adjusted with degrees of freedom (R**2), an indicator of the fit of 
each linear regression equation, was estimated. The R**2 of the TS and DT showed .992 
and .942, respectively, and the RMSE of the TS and DT showed .080 and .082, respectively. 
This result suggests that the residual stress distribution of tablets is a good estimator for TS 
and DT. 
Figure 26 shows the intensity of the residual stress distribution of tablets, which gives high 
TS and DT. Horizontal and vertical arrows show the intensity of x and y axial stresses. 
Circles indicate shear stresses. Blue arrows and circles indicate that the TS or DT was small 
when the stress was close to zero. In contrast, red arrows and circles indicate that the TS or 
DT became large when the stress deviated from zero. The MRA revealed that TS was strongly 
affected by !! values at mid-center and ! values at top-center. On the other hand, DT was 
affected significantly by !! values at the top-center and bottom-corner, and ! values at 
top-center. In terms of the rule of common sense, it is recognized that a homogeneous 
distribution of residual stress is important to enhance TS. However, MRA results revealed 
that in some cases, heterogeneous distribution of residual stress might enhance TS. 
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Fig. 26. Two-dimensional maps for the residual stress distribution of tablets resulting in high 
(a) TS and (b) DT. Horizontal and vertical arrows indicate x and y axial stress (!!!!"#!!!), 
respectively. Circle indicates shear stress!!!!. Blue arrows indicate that TS or DT values 
become small when this stress is close to zero. Red arrows indicate that TS and DT values 
become large when the stress deviates from zero.
 
PLS regression was performed to understand further details of the influence of formulation 
factors on residual stress distribution. Calibration models for the TS and DT of tablets 
compressed at 5 kN were estimated using PLS. Statistical indices such as R2 (a determination 
coefficient), RMSEC and RMSEP of the calibration model for the TS were .95, .081 and .095, 
respectively, and those of the DT were .903, .085 and .100, respectively. Therefore, both TS 
and DT were predicted well with high accuracy from !! , !!  and ! values in tablets, 
suggesting that residual stress distribution can be used as CQAs in pharmaceutical 
development. To reveal the degree of incidence, two-dimensional maps of regression 
coefficients are shown in Fig. 27. The results revealed !! at the top corner, !! at the 
mid-center and !  at the bottom corner were very sensitive to the TS, and !!  at the 
top-middle, !! at the bottom-corner and ! at the bottom-corner had a significant influence 
on DT. This study clearly revealed that the residual stress distribution in the tablet became a 
significant contributor to the characteristics of TS and DT, although further investigation is 
needed to understand the detailed mechanism of these stress parameters. 
To control the residual stress distribution using the FEM, we could design an optimum 
tablet formulation with excellent pharmaceutical responses, such as high tensile strength and 
short disintegration time. Controlling the residual stress distribution leads not only to the 
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design of the optimum formulation and process variables, but also allows the mechanisms of 
the pharmaceutical responses of the tablet to be understood. 
 
Fig. 27. Two-dimensional maps for regression coefficients in PLS analysis for TS and DT 
using LOOCV. A series of residual stress distribution data was employed as explaining 
variables in PLS. (a) x axial stress (!!!, (b) y axial stress (!!! and (c) shear stress!!!! in PLS 
analysis of TS. (d) x axial stress (!!!, (e) y axial stress (!!! and (f) shear stress !!! in PLS 
analysis of DT. 
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4. Conclusion 
A direct shear test and RSM-S were applied to model the mechanical behavior of 
pharmaceutical powders composed of LAC, CS and MCC, based on the DPC model. The 
FEM was used to simulate compaction behavior of the powders. The numerical results 
revealed that the residual stress distribution of tablets was affected by formulation and 
compression force. In particular, the residual stress distribution of tablets composed of equal 
amounts of LAC, CS and MCC was more uniform than the tablets composed of 67% MCC 
and 33% LAC, with no CS. Results of the MRA and PLS regression demonstrated that the 
residual stress distribution of tablets was closely related to the characteristics of TS and DT. 
In conclusion, the residual stress distribution of tablets simulated by the DPC model using the 
FEM might be useful as novel CQAs in pharmaceutical development. 
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Summary 
 
When designing pharmaceutical products, the relationships between causal factors and 
pharmaceutical responses are intricate. Therefore, the formulators’ expertise and experience 
are essential in designing an acceptable product formulation. The empirical approach requires 
a prolonged development time and significant resources. In recent years, regulatory 
authorities such as the US Food and Drug Administration and the International Conference on 
Harmonisation (ICH) have promoted and requested the application of quality-by-design 
(QbD) principles to facilitate the exchange of complex information about chromatographic 
selectivity and critical resolution values to support better method control, including method 
transfer. In particular, according to the ICH Q8 guidelines, a scientific understanding of the 
formulation and manufacturing method is required.  
In recent years, statistical approaches have been used for seeking acceptable formulations 
of pharmaceuticals. Response surface method (RSM) includes statistical factorial 
experimental design, modeling between causal factors and response variables, and 
multi-objective optimization for selecting the best formulation under a set of experimental 
restrictions. Predictions based on traditional linear regression models are often limited and the 
results obtained occasionally exhibit poor estimation. On the other hand, there are advantages 
in the precise prediction of the optimal solution using the non-linear techniques, RSM-S. 
However, several difficulties are yet to be overcome regarding a non-linear technique such as 
RSM-S. For instance, no proper method of analyzing the relationships of the latent structure 
among the design variables and response variables, and evaluating the reliability of border of 
design space (DS) estimated by RSM-S. Moreover, the mechanistic understanding of 
pharmaceutical unit operations is limited. The purpose of this study was to overcome these 
problems and establish a valuable method. 
In Chapter 1, a Bayesian network (BN) was used to clarify the latent structure underlying 
the causal factors and pharmaceutical responses of a tablet containing solid dispersion (SD) of 
indomethacin (IMC). BN is a directed acyclic graphical approach that expresses the 
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probabilistic causal relationships among attributes, in which probabilistic relationships are 
expressed by nodes and the links connecting the nodes. In this chapter, I successfully 
determined the complex relationships between causal factors and pharmaceutical responses 
using BN modeling. Moreover, both the causal factors and responses were predicted by the 
BN model using conditional probability distributions (CPDs). 
Using RSM-S, we can understand nonlinear relationships between causal factors and 
response variables, and can estimate the high-integrity design space. However, the reliability 
of the nonlinear response surface estimated by RSM-S cannot be evaluated directly using 
conventional statistical quantities. In Chapter 2, a resampling method with replacement was 
applied to evaluate the reliability of border on the design space estimated by RSM-S and 
nonlinear design space considered reliability of border was set upped. The resampling method 
with replacement for statistical inference is a nonparametric approach to compute estimated 
standard errors, confidence intervals and hypothesis testing. I revealed RSM-S and this 
resampling method might be useful for estimating the reliability of nonlinear design space. 
A key goal of QbD is to identify the most important critical quality attributes (CQAs) and 
to understand their relationships with the product performance. It is needed to clarify the 
relationships among the variables, intermediates in-process materials, and pharmaceutical 
characteristics because the intermediates in process could be CQAs. In Chapter 3, a 
multivariate statistical technique was applied to the design of an orally disintegrating tablet 
and to clarify the causal correlation among variables of the manufacturing process and 
pharmaceutical responses. Orally disintegrating tablets (ODTs) composed mainly of mannitol 
were prepared via the wet-granulation method using crystal transition from the δ to the β form 
of mannitol. A latent structure analysis of the pharmaceutical formulations of the tablet 
performed using a Bayesian network led to the clear visualization of a causal connection 
among variables of the manufacturing process and tablet characteristics. This technique 
provides a better understanding of the complicated latent structure among variables of the 
manufacturing process and tablet characteristics. 
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In previous chapters, statistical techniques were applied to pharmaceutical design.  
However, the mechanistic understanding of pharmaceutical unit operations is limited. In 
Chapter 4, numerical investigation was used to pharmaceutical design. Tablet characteristics 
of tensile strength and disintegration time were predicted using residual stress distribution, 
simulated by the finite element method (FEM). The Drucker–Prager Cap (DPC) model was 
calibrated using a direct shear test and analysis of the hardening law of the powder. The 
constructed DPC model was fed into the analysis using the FEM, and the mechanical 
behavior of pharmaceutical powders during compaction was analyzed using the FEM. The 
tensile strength and disintegration time were predicted accurately from the residual stress 
distribution of tablets using multiple linear regression analysis and partial least squares 
regression analysis. This suggests that the residual stress distribution of tablets is related 
closely to the tensile strength and disintegration time. 
In conclusions, these findings suggest that proposed novel multivariate statistical 
approaches and numerical analysis method are useful tools for the pharmaceutical design 
under the QbD concept. 
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